Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 1467 entries
View as:

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

Phase: N/A Priority: Normal
NCT ID: NCT01461577 Org: User:
Start: 11/30/11 End: 12/31/12 Due: 12/31/13

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT00132951 Org: User:
Start: 10/31/04 End: 09/30/06 Due: 09/30/07

Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin

Phase: N/A Priority: Normal
NCT ID: NCT00622648 Org: User:
Start: 01/31/08 End: 12/31/10 Due: 12/31/11

MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

Phase: N/A Priority: Normal
NCT ID: NCT00174798 Org: User:
Start: 05/31/05 End: 05/31/06 Due: 05/31/07

Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00729027 Org: User:
Start: 07/31/08 End: 06/30/09 Due: 06/30/10

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT05718258 Org: User:
Start: 01/18/23 End: 01/29/24 Due: 01/29/25

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

Phase: N/A Priority: Normal
NCT ID: NCT00243178 Org: User:
Start: 07/31/03 End: 09/30/05 Due: 09/30/06

Dermacyd Delicata Breeze - Photo Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00668486 Org: User:
Start: 01/31/08 End: - Due: -

Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04659603 Org: User:
Start: 03/29/21 End: 01/19/25 Due: 01/19/26

Dermacyd Femina Delicata (Lactic Acid)- Photo Dermatological Evaluation of the Irritation and Sensitivity Potential

Phase: N/A Priority: Normal
NCT ID: NCT00705276 Org: User:
Start: 04/30/08 End: - Due: -

A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00704080 Org: User:
Start: 08/31/08 End: 02/28/13 Due: 02/28/14

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

Phase: N/A Priority: Normal
NCT ID: NCT06192576 Org: User:
Start: 04/16/24 End: 01/15/29 Due: 01/15/30

A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01930552 Org: User:
Start: 09/30/13 End: 12/31/14 Due: 12/31/15

A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01882868 Org: User:
Start: 07/31/13 End: 08/31/15 Due: 08/31/16

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT02859896 Org: User:
Start: 01/19/17 End: 11/12/25 Due: 11/12/26

Dermacyd Silver Floral (Lactic Acid) - Acceptability.

Phase: N/A Priority: Normal
NCT ID: NCT00933569 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03912259 Org: User:
Start: 12/19/18 End: 02/14/20 Due: 02/14/21

Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

Phase: N/A Priority: Normal
NCT ID: NCT00687037 Org: User:
Start: 01/31/08 End: - Due: -

Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01785329 Org: User:
Start: 02/28/13 End: 07/31/13 Due: 07/31/14

Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine

Phase: N/A Priority: Normal
NCT ID: NCT00636870 Org: User:
Start: 02/28/03 End: 01/31/04 Due: 01/31/05

Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines

Phase: N/A Priority: Normal
NCT ID: NCT00254917 Org: User:
Start: 10/31/03 End: 02/28/06 Due: 02/28/07

Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)

Phase: N/A Priority: Normal
NCT ID: NCT00296790 Org: User:
Start: 02/28/06 End: 02/28/07 Due: 02/28/08

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

Phase: N/A Priority: Normal
NCT ID: NCT06687980 Org: User:
Start: 11/25/24 End: 07/05/27 Due: 07/05/28

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

Phase: N/A Priority: Normal
NCT ID: NCT06687967 Org: User:
Start: 11/28/24 End: 07/05/27 Due: 07/05/28

Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3

Phase: N/A Priority: Normal
NCT ID: NCT05222906 Org: User:
Start: 04/18/22 End: 10/30/26 Due: 10/30/27